Literature DB >> 233729

Antimicrobial activity of metronidazole in anaerobic bacteria.

F P Tally, B R Goldin, N Sullivan, J Johnston, S L Gorbach.   

Abstract

The antimicrobial activity of metronidazole was investigated in anaerobic bacteria by use of time-viability studies. This antimicrobial agent has a rapid onset of bactericidal activity under proper reducing conditions. The bactericidal rates were not affected by inoculum size or nutritional requirements, nor by inhibition of growth and protein synthesis by chloramphenicol. Using supernatant fractions of actively growing cultures of susceptible organisms, we observed a disappearance of metronidazole and a loss of biological activity, but there was no significant change in preparations from resistant bacteria. The decrease in drug concentration with susceptible cells occurred during the time that its bactericidal action was being exerted. Extracts from susceptible organisms rapidly reduced the concentration of metronidazole, confirming previous observations which suggest that the drug acts as a terminal electron acceptor. Radioisotope experiments with [14C]metronidazole revealed that the compound was taken up by both resistant and susceptible bacteria, although there was a difference in rate and extent of accumulation. These studies demonstrate that metronidazole's antimicrobial activity against anaerobic bacteria is bactericidal and independent of growth rate, and that it involves the uptake and metabolism of the compound.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 233729      PMCID: PMC352264          DOI: 10.1128/AAC.13.3.460

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  19 in total

1.  [The activity of 1-(2-hydroxyethyl)-2-methyl-5-nitroimidazole (R. P. 8823) against experimental Trichomonas vaginalis infections].

Authors:  C COSAR; L JULOU
Journal:  Ann Inst Pasteur (Paris)       Date:  1959-02

2.  In vitro studies on the differential toxicity of metronidazole in protozoa and mammalian cells.

Authors:  H B Tanowitz
Journal:  Ann Trop Med Parasitol       Date:  1975-03

3.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

4.  Metronidazole and amebiasis.

Authors:  E D Everett
Journal:  Am J Dig Dis       Date:  1974-07

5.  The mode of action of metronidazole in Trichomonas vaginalis and other micro-organisms.

Authors:  R M Ings; J A McFadzean; W E Ormerod
Journal:  Biochem Pharmacol       Date:  1974-05-01       Impact factor: 5.858

6.  Microbiological agar diffusion assay for metronidazole concentrations in serum.

Authors:  M E Levison
Journal:  Antimicrob Agents Chemother       Date:  1974-05       Impact factor: 5.191

7.  Antibiotic susceptibility of gram-negative bacilli isolated from blood cultures. Results of tests with 35 agents and strains from 169 patients at Boston City Hospital during 1972.

Authors:  J E McGowan; C Garner; C Wilcox; M Finland
Journal:  Am J Med       Date:  1974-08       Impact factor: 4.965

8.  Unique bactericidal action of metronidazole against Bacteroides fragilis and Clostridium perfringens.

Authors:  E D Ralph; W M Kirby
Journal:  Antimicrob Agents Chemother       Date:  1975-10       Impact factor: 5.191

9.  Prophylactic oral antimicrobial agents in elective colonic surgery. A controlled trial.

Authors:  J Goldring; W McNaught; A Scott; G Gillespie
Journal:  Lancet       Date:  1975-11-22       Impact factor: 79.321

10.  Antitrichomonad action, mutagenicity, and reduction of metronidazole and other nitroimidazoles.

Authors:  D G Lindmark; M Müller
Journal:  Antimicrob Agents Chemother       Date:  1976-09       Impact factor: 5.191

View more
  13 in total

1.  Differentiation of obligate anaerobes by assay of pyruvate:ferredoxin oxidoreductase activity.

Authors:  S Narikawa; M Nakamura
Journal:  Eur J Clin Microbiol       Date:  1987-02       Impact factor: 3.267

2.  Potentially synergistic antimicrobial combinations with metronidazole against Bacteroides fragilis.

Authors:  E D Ralph; Y E Amatnieks
Journal:  Antimicrob Agents Chemother       Date:  1980-03       Impact factor: 5.191

Review 3.  Periodontal disease as a specific, albeit chronic, infection: diagnosis and treatment.

Authors:  W J Loesche; N S Grossman
Journal:  Clin Microbiol Rev       Date:  2001-10       Impact factor: 26.132

4.  Properties of a new penicillinase type produced by Bacteroides fragilis.

Authors:  K Sato; Y Matsuura; M Inoue; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1982-10       Impact factor: 5.191

Review 5.  Metronidazole in anaerobic infections: a review of its activity, pharmacokinetics and therapeutic use.

Authors:  R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1978-11       Impact factor: 9.546

6.  Metronidazole in treatment against Haemophilus vaginalis (Corynebacterium vaginale).

Authors:  E D Ralph; Y E Amatnieks
Journal:  Antimicrob Agents Chemother       Date:  1980-07       Impact factor: 5.191

7.  Isolation and properties of metronidazole-resistant mutants of Bacteroides fragilis.

Authors:  M L Britz; R G Wilkinson
Journal:  Antimicrob Agents Chemother       Date:  1979-07       Impact factor: 5.191

8.  Ferredoxin-linked reduction of metronidazole in Clostridium pasteurianum.

Authors:  D L Lockerby; H R Rabin; L E Bryan; E J Laishley
Journal:  Antimicrob Agents Chemother       Date:  1984-11       Impact factor: 5.191

9.  Inactivation of metronidazole by anaerobic and aerobic bacteria.

Authors:  E D Ralph; D A Clarke
Journal:  Antimicrob Agents Chemother       Date:  1978-09       Impact factor: 5.191

10.  Comparative penetration of metronidazole, clindamycin, chloramphenicol, cefoxitin, ticarcillin, and moxalactam into bone.

Authors:  J T Summersgill; L G Schupp; M J Raff
Journal:  Antimicrob Agents Chemother       Date:  1982-04       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.